name:-0.12414789199829
name:-0.092375993728638
name:-0.022745132446289
Malloy; Timothy M. Patent Filings

Malloy; Timothy M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Malloy; Timothy M..The latest application filed is for "parenteral formulation for epothilone analogs".

Company Profile
0.10.12
  • Malloy; Timothy M. - Yardley PA
  • Malloy; Timothy M. - Bridgeport PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Parenteral Formulation For Epothilone Analogs
App 20150218179 - Bandyopadhyay; Rebanta ;   et al.
2015-08-06
Parenteral Formulation For Epothilone Analogs
App 20140107169 - Bandyopadhyay; Rebanta ;   et al.
2014-04-17
Parenteral formulation for epothilone analogs
Grant 8,632,788 - Bandyopadhyay , et al. January 21, 2
2014-01-21
FACTOR Xa INHIBITOR FORMULATION AND METHOD
App 20090291913 - Nassar; Munir N. ;   et al.
2009-11-26
Parenteral Formulation For Epothilone Analogs
App 20090069393 - Bandyopadhyay; Rebanta ;   et al.
2009-03-12
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
Grant RE40,387 - Bandyopadhyay , et al. June 17, 2
2008-06-17
FACTOR Xa INHIBITOR FORMULATION AND METHOD
App 20070191306 - Nassar; Munir N. ;   et al.
2007-08-16
Polymorphs of an epothilone analog
Grant 7,153,879 - DiMarco , et al. December 26, 2
2006-12-26
Parenteral formulation for epothilone analogs
Grant 7,022,330 - Bandyopadhyay , et al. April 4, 2
2006-04-04
Polymorphs of an epothilone analog
App 20060063815 - DiMarco; John D. ;   et al.
2006-03-23
Parenteral formulation for epothilone analogs
App 20060013836 - Bandyopadhyay; Rebanta ;   et al.
2006-01-19
Polymorphs of an epothilone analog
Grant 6,982,276 - DiMarco , et al. January 3, 2
2006-01-03
Polymorphs of an epothilone analog
App 20040157897 - DiMarco, John D. ;   et al.
2004-08-12
Polymorphs of an epothilone analog
Grant 6,689,802 - DiMarco , et al. February 10, 2
2004-02-10
Methods of administering epothilone analogs for the treatment of cancer
Grant 6,670,384 - Bandyopadhyay , et al. December 30, 2
2003-12-30
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
Grant 6,576,651 - Bandyopadhyay , et al. June 10, 2
2003-06-10
Polymorphs of an epothilone analog
App 20020188014 - DiMarco, John D. ;   et al.
2002-12-12
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
App 20020177615 - Bandyopadhyay, Rebanta ;   et al.
2002-11-28
Methods of administering epothilone analogs for the treatment of cancer
App 20020169190 - Bandyopadhyay, Rebanta ;   et al.
2002-11-14
Parenteral formulation for epothilone analogs
App 20020143038 - Bandyopadhyay, Rebanta ;   et al.
2002-10-03
Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
Grant 6,218,375 - Raghavan , et al. April 17, 2
2001-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed